Editas Medicine, Inc. (EDIT)

2.44 -0.09 (-3.56%) USD  |  NASDAQ  |  Dec 15, 16:00
2.44 0.00 (0.00%) After-Hours: 07:48
More

Editas Medicine Research and Development Expense (Annual): 193.44M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for EDIT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
ADMA Biologics, Inc. 1.813M
Arcutis Biotherapeutics, Inc. 76.42M
Daré Bioscience, Inc. 14.21M
Cogent Biosciences, Inc. 228.26M
Janux Therapeutics, Inc. 68.39M